Published in J Immunol on September 30, 2011
Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev (2015) 1.64
Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. MBio (2013) 1.41
Characteristics of human infection with avian influenza viruses and development of new antiviral agents. Acta Pharmacol Sin (2013) 0.94
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis. Future Virol (2012) 0.93
Chlorine gas exposure increases susceptibility to invasive lung fungal infection. Am J Physiol Lung Cell Mol Physiol (2013) 0.92
Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model. J Immunol (2013) 0.92
Local IL-17A potentiates early neutrophil recruitment to the respiratory tract during severe RSV infection. PLoS One (2013) 0.91
Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses. PLoS One (2013) 0.91
Th17 lymphocytes in respiratory syncytial virus infection. Viruses (2013) 0.88
Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk. PLoS One (2014) 0.85
Impaired gamma delta T cell-derived IL-17A and inflammasome activation during early respiratory syncytial virus infection in infants. Immunol Cell Biol (2014) 0.84
IRF3 deficiency impacts granzyme B expression and maintenance of memory T cell function in response to viral infection. Microbes Infect (2015) 0.80
Interleukin-17 (IL-17) and IL-1 activate translation of overlapping sets of mRNAs, including that of the negative regulator of inflammation, MCPIP1. J Biol Chem (2013) 0.79
IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy. Virchows Arch (2012) 0.79
Vaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a DNA vaccine encoding the measles virus hemagglutinin and fusion proteins. J Virol (2013) 0.79
Potent anti-inflammatory effects of the narrow spectrum kinase inhibitor RV1088 on rheumatoid arthritis synovial membrane cells. Br J Pharmacol (2015) 0.78
Deficiency of autophagy protein Map1-LC3b mediates IL-17-dependent lung pathology during respiratory viral infection via ER stress-associated IL-1. Mucosal Immunol (2015) 0.78
Synergistic Proinflammatory Responses by IL-17A and Toll-Like Receptor 3 in Human Airway Epithelial Cells. PLoS One (2015) 0.77
CD1d Expression and Invariant NKT Cell Responses in Herpesvirus Infections. Front Immunol (2015) 0.76
Pretreatment with a heat-killed probiotic modulates monocyte chemoattractant protein-1 and reduces the pathogenicity of influenza and enterovirus 71 infections. Mucosal Immunol (2016) 0.76
Interleukin-17 SNPs and serum levels increase ulcerative colitis risk: a meta-analysis. World J Gastroenterol (2014) 0.75
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol (2011) 5.11
A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol (2008) 3.34
Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med (2008) 2.77
The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci U S A (2002) 2.72
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science (2010) 2.56
Chronic bacterial infections: living with unwanted guests. Nat Immunol (2002) 1.80
An antiinflammatory role for IKKbeta through the inhibition of "classical" macrophage activation. J Exp Med (2008) 1.77
Benzodiazepine augmented γ-amino-butyric acid signaling increases mortality from pneumonia in mice. Crit Care Med (2013) 1.56
Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer. Clin Cancer Res (2004) 1.53
An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur J Immunol (2006) 1.44
A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J Exp Med (2003) 1.35
Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J Virol (2006) 1.33
Immune homeostasis in the respiratory tract and its impact on heterologous infection. Semin Immunol (2009) 1.30
Interferon-β production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity (2013) 1.27
Transcriptional changes underlying the secretory activation phase of mammary gland development. Mol Endocrinol (2005) 1.23
Sedation & immunomodulation. Crit Care Clin (2009) 1.21
The impact of successive infections on the lung microenvironment. Immunology (2007) 1.21
Role of CCL5 (RANTES) in viral lung disease. J Virol (2006) 1.21
IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood (2010) 1.15
The microbiology of asthma. Nat Rev Microbiol (2012) 1.14
Disturbed blood flow induces RelA expression via c-Jun N-terminal kinase 1: a novel mode of NF-κB regulation that promotes arterial inflammation. Circ Res (2011) 1.14
Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infection. J Virol (2005) 1.12
Respiratory infections: do we ever recover? Proc Am Thorac Soc (2007) 1.11
Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection. J Infect Dis (2011) 1.04
Airway immune homeostasis and implications for influenza-induced inflammation. Trends Immunol (2011) 1.03
Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis. Arthritis Rheumatol (2014) 1.02
Radioresistant cells expressing TLR5 control the respiratory epithelium's innate immune responses to flagellin. Eur J Immunol (2009) 0.98
Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner. Eur J Immunol (2005) 0.97
Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. Stem Cells (2011) 0.97
The chemokine MIP1alpha/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung. PLoS One (2010) 0.96
Evolution of a polymorphic regulatory element in interferon-gamma through transposition and mutation. Mol Biol Evol (2002) 0.95
In the absence of reactive oxygen species, T cells default to a Th1 phenotype and mediate protection against pulmonary Cryptococcus neoformans infection. J Immunol (2006) 0.95
Recombinant respiratory syncytial virus lacking secreted glycoprotein G is attenuated, non-pathogenic but induces protective immunity. Microbes Infect (2004) 0.94
An IL-7 fusion protein that shows increased thymopoietic ability. J Immunol (2005) 0.94
Boosting of cellular immunity against Mycobacterium tuberculosis and modulation of skin cytokine responses in healthy human volunteers by Mycobacterium bovis BCG substrain Moreau Rio de Janeiro oral vaccine. Infect Immun (2006) 0.94
Innate imprinting by the modified heat-labile toxin of Escherichia coli (LTK63) provides generic protection against lung infectious disease. J Immunol (2004) 0.93
A critical role for ICOS co-stimulation in immune containment of pulmonary influenza virus infection. Eur J Immunol (2006) 0.92
Macrophage-mediated inflammation and disease: a focus on the lung. Mediators Inflamm (2012) 0.91
Accuracy and reproducibility of protein-DNA microarray technology. Adv Biochem Eng Biotechnol (2007) 0.90
OX40 ligation on activated T cells enhances the control of Cryptococcus neoformans and reduces pulmonary eosinophilia. J Immunol (2003) 0.89
TGF-beta prevents eosinophilic lung disease but impairs pathogen clearance. Microbes Infect (2005) 0.89
Amelioration of influenza-induced pathology in mice by coinfection with Trichinella spiralis. Infect Immun (2006) 0.89
Protection against tetanus toxin using a plant-based vaccine. Eur J Immunol (2005) 0.88
Themis2/ICB1 is a signaling scaffold that selectively regulates macrophage Toll-like receptor signaling and cytokine production. PLoS One (2010) 0.88
Evolution of vertebrate immunity: sequence and functional analysis of the SEFIR domain family member Act1. J Mol Evol (2011) 0.88
OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis. Proc Natl Acad Sci U S A (2014) 0.86
Epidemiological isolation causing variable mortality in Island populations during the 1918-1920 influenza pandemic. Influenza Other Respir Viruses (2012) 0.86
Colonic bacterial infection abrogates eosinophilic pulmonary disease. J Infect Dis (2005) 0.85
Discovery of a vaccine antigen that protects mice from Chlamydia pneumoniae infection. Vaccine (2006) 0.84
FOXO3 as a new IKK-ε-controlled check-point of regulation of IFN-β expression. Eur J Immunol (2012) 0.84
Prior exposure to live Mycobacterium bovis BCG decreases Cryptococcus neoformans-induced lung eosinophilia in a gamma interferon-dependent manner. Infect Immun (2003) 0.83
The acquired immune response to the mucosal adjuvant LTK63 imprints the mouse lung with a protective signature. J Immunol (2007) 0.82
Implications of inter-population linkage disequilibrium patterns on the approach to a disease association study in the human MHC class III. Immunogenetics (2006) 0.81
Cross-species analysis reveals evolving and conserved features of the nuclear factor κB (NF-κB) proteins. J Biol Chem (2013) 0.80
Is it wise to target the late costimulatory molecule OX40 as a therapeutic target? Arch Immunol Ther Exp (Warsz) (2008) 0.80
OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection. J Infect Dis (2012) 0.80
Sedation & immunomodulation. Anesthesiol Clin (2011) 0.79
Manipulation of immunity to and pathology of respiratory infections. Expert Rev Anti Infect Ther (2004) 0.77
IL-17 receptor adaptor protein Act1/CIKS plays an evolutionarily conserved role in antiviral signaling. J Immunol (2012) 0.77
Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines. Vaccine (2004) 0.76
Parenteral fluids do not affect pulmonary immune responses to influenza or susceptibility to secondary bacterial pneumonia in mice. Influenza Other Respir Viruses (2012) 0.75
Bacterial superinfection following lung inflammatory disorders. Future Microbiol (2013) 0.75
Anti-TNF Therapy. Microbiol Spectr (2016) 0.75